ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1277

US Adult Rheumatologists Perspective on the Transition Process for Young Adults with Rheumatic Conditions

Devy Zisman1,2, Patience White3, Peter Chira4, Stacy P. Ardoin5, Erica F. Lawson6, Emily von Scheven7, Idit Lavi8, Laura Tarter9 and Elizabeth D. Mellins10, 1Technion, The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel, 2Carmel Medical Center, Haifa, Israel, 3Department of Medicine, Division of Rheumatology, The George Washington University, Washington, DC, 4Pediatric Rheumatology, University of California San Diego, Rady Children's Hospital, San Diego, CA, 5Pediatric & Adult Rheumatology, Ohio State University, Columbus, OH, 6Pediatrics, University of California San Francisco, San Francisco, CA, 7Dept of Pediatric Rheumatology, Univ of California San Francisco, San Francisco, CA, 8Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel, 9Rheumatology, Stanford University Hospital, Stanford, CA, 10Dept of Pediatrics CCSR, Stanford University Med Ctr, Stanford, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Transition and young adults

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Health Services Research Poster II (ACR): Healthcare Access, Patterns of Medication Use and Workforce Considerations

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: To assess the attitudes and common practices of adult rheumatologists in US regarding transition of young adults with rheumatic diseases from pediatric to adult care.

Methods: An online survey was sent to adult and combined adult and pediatric rheumatologist members of the ACR who practice in U.S. The anonymous questionnaire included demographic data, questions about attitudes and common practices regarding the transition process.

Results: 203 of 4064 (5%) rheumatologists completed the survey. Among them, 178 (87.7%) were board certified in rheumatology and 11 (5.4%) were certified in adult and pediatric rheumatology; 14 (16.9%) were fellows. 92 (45.7%) work in a university clinic and 85 (42.9%) in private practice, 67 (34%) had practiced <10 years and 113 (57.6%) >15 years. 88 (45.1%) were never trained in transition practices, and 133 (74.7%) were not familiar with the American Academy of Pediatrics consensus statement about   transition care for youth with special healthcare needs. 71 (37%) had not developed a plan for integrating former pediatric patients into their practice; 43 (22.4%) do not have a written transition policy, but follow an informal procedure and 27 (14.1%) do not think that a transition policy is needed. Only 105 (56.15%) feel comfortable caring for former pediatric patients. The vast majority do not have a multidisciplinary team to integrate new young adults into their practice [175 (90.7%)]; 165 (86.8%) do not have a designated staff responsible for coordinating the integration. For 153 (80.1%), the patient is referred by a pediatric rheumatologist, or adult primary care [111; (58.1%)] for 106 (55.5%), the patient is self-referred. The median age of transition is 18-20 years. Time from last pediatric rheumatology visit to first adult rheumatology visit is 3-6 months in 70 (40.7%) and between 6-12 months in 67 (38.9%). The physicians were dysatisfied with the following data received: previous treatments 85 (48.9%), hospitalization history 83 (48%), disease activity index 78 (45.1%), medical history summary 76 (43.9%), co-morbidities 63 (36.4%), medication list 59 (34.1%) and disease classification 56 (32.6%). Only a minority were satisfied with the current integration process [12 (7.14%)], have sufficient resources and personnel [15 (8.93%)] and time in clinic [22 (13.1%)].  The 3 major barriers to the integration process are lack of insurance reimbursement [57 (33.9%)], lack of knowledge about community resources to support patients [52 (31.3%)] and lapse in care between primary provider and specialist [47 (28%)]. The vast majority need tools to facilitate transition 133 (79.6%) and desire a specific rheumatology consensus statement with guidelines for transitioning adolescent rheumatology patients to adult-centered care 141 (83.9%). No significant differences were noted between practitioners in university clinics vs private practice or between those practicing for less or more than 15 years.  

Conclusion: This survey of rheumatologists caring for adults demonstrated substantial gaps in knowledge and resources regarding transition from pediatric to adult care for young adults with rheumatic diseases. Practice guidelines may be an effective way to address these gaps.


Disclosure: D. Zisman, None; P. White, None; P. Chira, None; S. P. Ardoin, None; E. F. Lawson, None; E. von Scheven, None; I. Lavi, None; L. Tarter, None; E. D. Mellins, Novartis, Glaxo-Smith-Kline, 2,Ascendent, Codexis, 5.

To cite this abstract in AMA style:

Zisman D, White P, Chira P, Ardoin SP, Lawson EF, von Scheven E, Lavi I, Tarter L, Mellins ED. US Adult Rheumatologists Perspective on the Transition Process for Young Adults with Rheumatic Conditions [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/us-adult-rheumatologists-perspective-on-the-transition-process-for-young-adults-with-rheumatic-conditions/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/us-adult-rheumatologists-perspective-on-the-transition-process-for-young-adults-with-rheumatic-conditions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology